Neurofilament light chain is a promising noninvasive biomarker for multiple sclerosis (MS), but lacks disease specificity due to other neurological causes. Apolipoprotein levels are negatively ...

Some research suggests that people with multiple sclerosis are at a higher risk of atherosclerosis. An increased risk hasn’t been established, and we don’t know how MS might increase the risk. Having ...

More research is necessary to understand cerebral oxygen consumption as a predictive biomarker for brain atrophy in multiple sclerosis (MS); however, this study found that mitochondrial dysfunction ...

Multiple sclerosis (MS) is driven by a complex interplay of adaptive and innate immune processes that breach central nervous system (CNS) immune privilege. Autoreactive CD4+ T cells, notably T helper ...

Multiple sclerosis (MS) exhibits a notable seasonal pattern in both clinical expression and underlying pathophysiology. The interplay between environmental factors and immune regulation underpins ...

Increasing evidence suggests that the severe gum disease, periodontitis, may contribute to central nervous system disorders through chronic inflammation. However, its role in multiple sclerosis, a ...

People with multiple sclerosis (MS) have compromised immune systems. Certain disease-modifying therapies (DMTs) used for treating MS may weaken and make changes to the immune system. MS is an ...

Living with multiple sclerosis (MS) often means dealing with different kinds of pain some caused by damage to nerves, some by muscle stiffness or spasms, and some related to changes in how the body ...